CRSP stock: buy or sell

CRSP stock price: $123.85 0.60% At close on Apr 15th, 2021

Updated on:
Apr 16th, 2021

1

CRSP stock brief

  • CRISPR Therapeutics stock slightly changed 0.60% to close at $123.85 on the stock market today, after 3 consecutive sessions in green.
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases.

Should I buy CRISPR Therapeutics stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $CRSP stock a buy?

In the current situation of CRISPR Therapeutics there is not any eligible buy setup. This doesn't mean we expect a selloff for $CRSP in coming sessions, or that it may not climb higher. Simply, it doesn't match our recommended trading systems

Should I sell CRISPR Therapeutics stock?

How to know when is it time to sell CRISPR Therapeutics stock?. Much like when we have to buy shares, deciding when is appropiate to sell is not a fickle decision, and we must use our own trading style. Our trading system selects very simple strategies to guide us on when is the best time to sell a stock. Be aware that these strategies should not be used for selling short $CRSP stock

As a golden rule, you must never keep a trading operation that shows a higher than expected losses upon purchase. When to sell shares should always be dictated by the stop-loss (automatic or manual)

Is it time to sell CRISPR Therapeutics stock?

Currently, CRISPR Therapeutics stock doesn't match any of our preferred sell setups, so if you hold CRISPR Therapeutics stock and your operation is in profit probably is not time to sell now

CRISPR Therapeutics ratings

We don't have any rating posted in the previous month for CRISPR Therapeutics

CRISPR Therapeutics stock analysis

SMAs overview

CRSP stock SMAs chart

Supports and resistances

The current resistances are:

  • R1: $129.27 (4.38% above)
  • R2: $137.00 (10.62% above)
  • R3: $220.20 (77.80% above)
  • The current supports are:

  • S1: $111.90 (-9.65% below)
  • S2: $106.50 (-14.01% below)
  • S3: $105.12 (-15.12% below)
  • Bollinger bands

    CRSP stock Bollinger Bands chart

    Relative strength index

    The RSI crossed up the oversold level of 30 in early March after just being in the oversold zone for a single day (what can be considered a strength signal). The RSI value on Thursday was 50.14. CRISPR Therapeutics stock exploded a 9.00% since RSI left the oversold zone

    CRSP stock RSI chart

    CRISPR Therapeutics stock price history

    CRISPR Therapeutics started trading on Oct 19th, 2016 at $15.00 per share1. Since then, CRSP stock surged by 725.67%, with an average of 181.42% per year. If you had invested thousand dollars in CRISPR Therapeutics stock on Oct 2016, it would have a value of $8,256.67 today.

    1: Adjusted price after possible price splits or reverse-splits

    CRSP stock price history chart

    Price target for CRISPR Therapeutics stock

    Nobody can predict how much a stock will be priced tomorrow. Banks and financial organisations publish their analysis predicting how a stock will performance in the future.

    The following table shows the price forecasts published by analysts in the last 30 days. Again, these forecasts are not direct recommendations for individual investors and must not be trusted blindly.

    In the previous month we couldn't find any price target published for CRISPR Therapeutics stock.

    Earnings and financials

    CRISPR Therapeutics AG ($CRSP) released earnings of $-1.50 per share last February, significantly worsening the Market consensus estimate of $-1.27 per share. This quarterly report represents an earnings surprise of -18.11%.

    Compared to the same quarter last year, EPS was $0.51, so posted EPS means a drop of -394.12%. Looking at revenue, figures sank a -99.52% compared to $770.2M same quarter a year ago.

    CRSP ($CRSP) is posting financial report on April 27. Analysts expect of $-1.49, that is a 0.67% higher than Q4.

    CRISPR Therapeutics performance

    CRSP performance compared
    Company1m3m6m
    CRISPR Therapeutics ($CRSP) -1.80% -37.10% 19.20%

    Please read:
    The opinions expressed in this post are personal and not recommendations for you to buy or sell shares. The author of this report does not have any knowledge of the individual positions of the reader, his or her finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Comments are published for learning purposes only

    CRSP summary

    Thursday, April 15th, 2021
    Open$125
    Close$123.85
    Day range$121.83 - $126.7
    Previous close$123.11
    Session gain0.60%
    Average true range$8.48
    50d mov avg$132.45
    100d mov avg$145.89
    200d mov avg$118.60
    Earnings dateApril 27th, 2021

    Frequently asked questions

    What is CRISPR Therapeutics stock symbol?

    CRISPR Therapeutics AG is a public company trading in the US stock market with the CRSP symbol

    Is CRISPR Therapeutics stock a buy or sell?

    CRISPR Therapeutics had no ratings in the last four weeks Read the article to get additional tips on trading CRSP stock.

    Will CRSP go up?

    There were no price targets published by analysts in the last month for CRISPR Therapeutics.